The Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL) with Everolimus Results in Clinical Responses and Mobilization of CLL Cells into the Circulation

BACKGROUND: Patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL) often have chemotherapy resistant disease resulting in a poor prognosis. The aim of this study was to learn if inhibition of the mammalian target of rapamycin (mTOR) would produce tumor respon...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Zent, Clive S., LaPlant, Betsy R., Johnston, Patrick B., Call, Timothy G., Habermann, Thomas M., Micallef, Ivana N., Witzig, Thomas E.
Format: Artigo
Idioma:Inglês
Publicat: 2010
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2861142/
https://ncbi.nlm.nih.gov/pubmed/20166206
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.25005
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars